JY
KYTH

Jeff Yass’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Jeff Yass’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-94,100
Closed -$7.06M – 10590
2015
Q3 		$7.06M Sell
94,100
-120,200
-56% -$8.98M ﹤0.01% 2235
2015
Q2 		$16.1M Buy
214,300
+58,100
+37% +$3.11M 0.01% 1515
2015
Q1 		$7.83M Buy
156,200
+129,700
+489% +$5.44M ﹤0.01% 2148
2014
Q4 		$919K Sell
26,500
-28,600
-52% -$998K ﹤0.01% 6040
2014
Q3 		$1.8M Sell
55,100
-9,200
-14% -$324K ﹤0.01% 4790
2014
Q2 		$2.47M Buy
64,300
+51,600
+406% +$1.8M ﹤0.01% 4249
2014
Q1 		$505K Buy
+12,700
New +$568K ﹤0.01% 6729

Jeff Yass's KYTH Position: Q4 2015 in Review

Jeff Yass sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 36,461 shares — an estimated $2.73M sold.

Jeff Yass first reported a position in KYTH in Q3 2013 and held it in 9 quarters. The position peaked at $18.6M in Q2 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Jeff Yass reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Jeff Yass sold 36,461 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $2.73M.
  • Jeff Yass first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q3 2013 and held it in 9 quarters.
  • Jeff Yass's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $18.6M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Susquehanna International Group's 13F filing for Q4 2015, filed 16 Feb 2016.